Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials

Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials

Abstract Background Long-acting injectable antiretroviral therapy (LA ART) has been shown to be non-inferior to daily oral ART, with high patient satisfaction and preference to oral standard of care in research to date, and has recently been approved for use in the United States and Europe. This stu...

Full description

Bibliographic Details
Main Authors: Andrea Mantsios, Miranda Murray, Tahilin S. Karver, Wendy Davis, Noya Galai, Princy Kumar, Susan Swindells, U. Fritz Bredeek, Rafael Rubio García, Antonio Antela, Santiago Cenoz Gomis, Miguel Pascual Bernáldez, Maggie Czarnogorski, Krischan Hudson, Nicki Walters, Deanna Kerrigan
Format: Article
Language:English
Published: BMC 2021-03-01
Series:BMC Health Services Research
Subjects:
HIV
ART
Long-acting injectable
Implementation
Health care providers
Clinical settings
Online Access:https://doi.org/10.1186/s12913-021-06214-9

Internet

https://doi.org/10.1186/s12913-021-06214-9

Similar Items